CoChat

Structural basis for exploring the allosteric inhibition of human kidney type glutaminase

Open access
Ramachandran, Sarath, Pan, Catherine Qiurong, Zimmermann, Sarah C., Duvall, Bridget, Tsukamoto, Takashi, Low, Boon Chuan, Sivaraman, J. · 2016 · Oncotarget
Cited by 47

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Sarath Ramachandran 1 , Catherine Qiurong Pan 2 , Sarah C. Zimmermann 3 , Bridget Duvall 3 , Takashi Tsukamoto 3 , Boon Chuan Low 1, 2 , J. Sivaraman 1 1 Department of Biological Sciences, National University of Singapore, 117543, Singapore 2 Mechanobiology Institute Singapore, National University of Singapore, 117411, Singapore 3 Department of Neurology and Johns Hopkins Drug Discovery Program, Johns Hopkins University, Baltimore, Maryland 21205, USA Correspondence to: J. Sivaraman, email: dbsjayar@nus.edu.sg Keywords: glutaminase, cancer target, BPTES, CB-839, allosteric inhibitors Received: November 30, 2015 Accepted: June 17, 2016 Published: July 22, 2016 ABSTRACT Cancer cells employ glutaminolysis to provide a source of intermediates for their upregulated biosynthetic needs. Glutaminase, which catalyzes the conversion of glutamine to glutamate, is gaining increasing attention as a potential drug target. Small-molecule inhibitors such as BPTES and CB-839, which target the allosteric site of glutaminase with high specificity, demonstrate immense promise as anti-tumor drugs. Here, we report the study of a new BPTES analog, N,N′-(5,5′-( trans -cyclohexane-1,3-diyl)bis(1,3,4-tiadiazole-5,2-diyl))bis(2-phenylacetamide) (trans-CBTBP), and compared its inhibitory effect against that of CB-839 and BPTES. We show that CB-839 has a 30- and 50-fold lower IC 50 than trans-CBTBP and BPTES, respectively. To explore the structural basis for the differences in their inhibitory efficacy, we solved the complex structures of cKGA with 1 S , 3 S -CBTBP and CB-839. We found that CB-839 produces a greater degree of interaction with cKGA than 1 S , 3 S -CBTBP or BPTES. The results of this study will facilitate the rational design of new KGA inhibitors to better treat glutamine-addicted cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.10791

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 47

Metadata

Authors
Ramachandran, S., Pan, C. Q., Zimmermann, S. C., Duvall, B., Tsukamoto, T., Low, B. C., & Sivaraman, J.
Venue
Oncotarget
Published
2016-07-22
Volume
7
Issue
36
Pages
57943-57954
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2488460578
Cited by
47
References
12
FWCI
2.32
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.